These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 1479220
21. [Oxidized fatty acid and PPAR-gamma]. Kita T, Arai H. Nihon Rinsho; 2001 Mar; 59 Suppl 3():823-30. PubMed ID: 11347181 [No Abstract] [Full Text] [Related]
22. [Contemporary views on the etiology and pathogenesis of atherosclerosis]. Draganov V, Balutsov M, Lazarov S. Vutr Boles; 2000 Mar; 32(4):25-32. PubMed ID: 11688327 [Abstract] [Full Text] [Related]
23. Role of oxidative modifications in atherosclerosis. Stocker R, Keaney JF. Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655 [Abstract] [Full Text] [Related]
24. [Role of hypercholesterolemia in the pathogenesis of atherosclerosis]. Bratus VV, Gavrish AS, Isaechkina IM. Fiziol Zh (1994); 1994 Oct; 40(1):64-70. PubMed ID: 7713228 [Abstract] [Full Text] [Related]
25. [Cholesterol and coronary risk]. Amann FW. Schweiz Rundsch Med Prax; 1989 May 16; 78(20):573-5. PubMed ID: 2740675 [No Abstract] [Full Text] [Related]
26. Can modification of risk factors reduce coronary heart disease? Grundy SM. Cardiovasc Clin; 1983 May 16; 13(1):283-96. PubMed ID: 6336670 [No Abstract] [Full Text] [Related]
31. [Role of macrophages in atherogenesis]. Rouis M, Nigon F, Chapman MJ. Presse Med; 1991 Mar 09; 20(9):401-3. PubMed ID: 1826774 [No Abstract] [Full Text] [Related]
32. The key role of histamine in the development of atherosclerosis and coronary heart disease. Clemetson CA. Med Hypotheses; 1999 Jan 09; 52(1):1-8. PubMed ID: 10342662 [Abstract] [Full Text] [Related]
33. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices]. Herrmann W, Reuter W. Z Gesamte Inn Med; 1982 Dec 15; 37(24):830-3. PubMed ID: 6963524 [No Abstract] [Full Text] [Related]
34. The management of hypercholesterolemia revisited. Wiggins BS. Manag Care Interface; 2001 Jan 15; 14(1):58-66, 72. PubMed ID: 11214536 [Abstract] [Full Text] [Related]
35. [Evaluation of the indicators of arteriosclerosis risk factors: cholesterol:HDL cholesterol and LDL cholesterol: HDL cholesterol in acute and chronic diseases of the liver]. Simon K, Kowalewski W, Dobracki W. Przegl Lek; 1987 Jan 15; 44(11):746-50. PubMed ID: 3447241 [No Abstract] [Full Text] [Related]
36. [Guidelines for management of patients with hypercholesterolemia]. Egusa G. Nihon Rinsho; 2001 Mar 15; 59 Suppl 3():500-4. PubMed ID: 11347120 [No Abstract] [Full Text] [Related]
37. [Lipoprotein metabolism and atherosclerosis--experimental principles]. Hüttinger M, Dudczak R. Vasa Suppl; 1987 Mar 15; 20():52-5. PubMed ID: 3480607 [No Abstract] [Full Text] [Related]
38. [Lipoproteins and the etiopathogenesis of atherosclerosis]. Dargel R. Zentralbl Allg Pathol; 1989 Mar 15; 135(6):501-4. PubMed ID: 2683496 [Abstract] [Full Text] [Related]
39. Rapid induction of atherosclerosis in rabbits. Saso Y, Kitamura K, Yasoshima A, Iwasaki HO, Takashima K, Doi K, Morita T. Histol Histopathol; 1992 Jul 15; 7(3):315-20. PubMed ID: 1504449 [Abstract] [Full Text] [Related]
40. [Molecular mechanisms of arteriosclerosis]. Kita T. Nihon Naika Gakkai Zasshi; 1999 Sep 10; 88(9):1706-11. PubMed ID: 10581750 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]